$129.25
arrow_drop_up0.71%Key Stats | |
---|---|
Open | $127.70 |
Prev. Close | $127.61 |
EPS | -3.20 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 126.30 | 131.51 |
52 Week Range | 59.22 | 136.60 |
Ratios | |
---|---|
EPS | -3.20 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Glaukos Stocks Rides on Strong Product Demand Amid Competition
Will WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings? - Zacks Investment Research
Truist lifts Glaukos shares target, highlights strong market position - Investing.com
This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Global Ophthalmic Devices Market Analysis Report 2024-2032 Featuring Johnson & Johnson, Topcon, Canon, Alcon ... - GlobeNewswire
Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?